PNC Financial Services Group’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,218
Closed -$2.88K – 5395
2026
Q2
$2.88K Buy
2,218
+1,511
+214% +$2.4K ﹤0.01% 4569
2026
Q1
$1.14K Buy
707
+649
+1,119% +$1.33K ﹤0.01% 4725
2025
Q4
$163 Sell
58
-178
-75% -$413 ﹤0.01% 5002
2025
Q3
$486 Buy
+236
New +$652 ﹤0.01% 4807
2025
Q1
– Sell
-1,520
Closed -$6.6K – 4922
2024
Q4
$6.6K Hold
1,520
– – ﹤0.01% 3949
2024
Q3
$4.06K Hold
1,520
– – ﹤0.01% 4099
2024
Q2
$3.37K Hold
1,520
– – ﹤0.01% 4111
2024
Q1
$8.12K Hold
1,520
– – ﹤0.01% 3817
2023
Q4
$2.25K Hold
1,520
– – ﹤0.01% 4172
2023
Q3
$2.11K Hold
1,520
– – ﹤0.01% 4226
2023
Q2
$2.23K Hold
1,520
– – ﹤0.01% 4350
2023
Q1
$2.51K Buy
1,520
+520
+52% +$893 ﹤0.01% 4251
2022
Q4
$1.4K Buy
+1,000
New +$1.43K ﹤0.01% 4339
2022
Q1
– Sell
-3,000
Closed -$18K – 4550
2021
Q4
$18K Buy
+3,000
New +$17.9K ﹤0.01% 3586
2019
Q4
– Sell
-1,000
Closed -$2K – 4003
2019
Q3
$2K Buy
+1,000
New +$1.95K ﹤0.01% 3845
2017
Q1
– Sell
-14
Closed -$2K – 4119
2016
Q4
$2K Buy
+14
New +$3.27K ﹤0.01% 3826

Other funds holding CRDF

PNC Financial Services Group's CRDF Position: Q3 2026 in Review

PNC Financial Services Group sold out of Cardiff Oncology (CRDF) in Q3 2026, closing a stake of 2,218 shares — an estimated $2.88K sold.

PNC Financial Services Group first reported a position in CRDF in Q4 2016 and held it in 16 quarters. The position peaked at $18K in Q4 2021. 63 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.

  • PNC Financial Services Group reported no remaining Cardiff Oncology position as of Q3 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 2,218 Cardiff Oncology shares in Q3 2026, an estimated $2.88K.
  • PNC Financial Services Group first reported a position in Cardiff Oncology in Q4 2016 and held it in 16 quarters.
  • PNC Financial Services Group's Cardiff Oncology position peaked at $18K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.